Zenavod

Zenavod is the yet-to-be-approved version of generic Oracea. Zenavod is 40mg of doxycycline. Patent protection for Oracea likely exists until the end of 2027.

Recent Rosacea Blog Posts

Zenavod (DFD-09) is the new Generic Oracea – sadly no

News today that Dr. Reddy’s subsidiary Promius Pharma has gained tentative approval for their 40mg formulation of doxycycline for the papules and pustles of rosacea. Before we get too excited about the real possibility of the availability of a generic form of Oracea, the announcement tells us that the approval is “subject to an automatic […]

Continue Reading

Promius files NDA for modified release tetracycline Zenavod (DFD-09)

Promius Pha rma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09. Promius Pharma is probably best know to rosacea sufferers via the availability of Promiseb Topical Cream in the US. Promiseb, a treatment for […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.